Literature DB >> 15157895

Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF).

Hiroki Ichiyama1, Shin Onodera, Jun Nishihira, Teruo Ishibashi, Toshinori Nakayama, Akio Minami, Kazunori Yasuda, Harukazu Tohyama.   

Abstract

OBJECTIVE: Previous studies have demonstrated that neutralization of macrophage migration inhibitory factor (MIF) by anti-MIF antibody decreases joint destruction in the collagen-induced arthritis model. The present study was undertaken to investigate whether selective deletion of MIF inhibits inflammation and joint destruction of the anti-type II collagen antibody (anti-CII Ab)/lipopolysaccharide (LPS)-induced arthritis in mice, in order to determine the role of this cytokine in inflammatory arthritis.
DESIGN: Anti-CII Ab/LPS-induced arthritis was induced in MIF-deficient and wild-type mice. The effects of anti-MIF polyclonal antibody administration on anti-CII Ab-induced arthritis were also evaluated.
RESULTS: The expression of MIF protein and mRNA was induced in anti-CII Ab/LPS-induced arthritis joint tissues. Histopathological arthritis scores for synovial inflammation induced by anti-CII Ab/LPS -induced arthritis were significantly decreased in anti-MIF Ab-treated mice and in MIF-deficient mice compared to wild-type mice. In addition, mRNA levels of MMP-13 and MIP-2 in anti-CII Ab/LPS-induced arthritis joint tissues were significantly reduced in MIF-deficient mice compared to wild-type control mice.
CONCLUSIONS: These results indicate that MIF plays a critical role in inflammation and joint destruction in the anti-CII Ab/LPS-induced arthritis model in mice, in part via induction of MMP-13 and neutrophil infiltration through the induction of MIP-2. Copyright 2004 Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157895     DOI: 10.1016/j.cyto.2004.02.007

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  21 in total

1.  Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions.

Authors:  Alexandru Movila; Takenobu Ishii; Abdullah Albassam; Wichaya Wisitrasameewong; Mohammed Howait; Tsuguno Yamaguchi; Montserrat Ruiz-Torruella; Laila Bahammam; Kazuaki Nishimura; Thomas Van Dyke; Toshihisa Kawai
Journal:  J Bone Miner Res       Date:  2016-06-02       Impact factor: 6.741

2.  Macrophage migration inhibitory factor: a regulator of MMP13 and inflammation in titanium particles-stimulated air pouch in vivo.

Authors:  Xiaoyun Pan; Xin Mao; Tao Cheng; Xianlong Zhang
Journal:  Mol Cell Biochem       Date:  2011-05-29       Impact factor: 3.396

Review 3.  Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Joshua B Bilsborrow; Edward Doherty; Pathricia V Tilstam; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2019-08-20       Impact factor: 6.902

4.  Cadherin-11 regulates fibroblast inflammation.

Authors:  Sook Kyung Chang; Erika H Noss; Mei Chen; Zhizhan Gu; Kirk Townsend; Rosa Grenha; Luis Leon; Soo Young Lee; David M Lee; Michael B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

5.  Neutralization of macrophage migration inhibitory factor (MIF) by fully human antibodies correlates with their specificity for the β-sheet structure of MIF.

Authors:  Randolf J Kerschbaumer; Manfred Rieger; Dirk Völkel; Didier Le Roy; Thierry Roger; Jurate Garbaraviciene; Wolf-Henning Boehncke; Jürgen Müllberg; Rene M Hoet; Clive R Wood; Gerhard Antoine; Michael Thiele; Helga Savidis-Dacho; Michael Dockal; Hartmut Ehrlich; Thierry Calandra; Friedrich Scheiflinger
Journal:  J Biol Chem       Date:  2012-01-11       Impact factor: 5.157

6.  Estradiol replacement therapy regulates innate immune response in ovariectomized arthritic mice.

Authors:  Ayda Henriques Schneider; Alexandre Kanashiro; Sabrina Graziani Veloso Dutra; Raquel do Nascimento de Souza; Flávio Protásio Veras; Fernando de Queiroz Cunha; Luis Ulloa; André Souza Mecawi; Luis Carlos Reis; David do Carmo Malvar
Journal:  Int Immunopharmacol       Date:  2019-05-02       Impact factor: 4.932

7.  Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication.

Authors:  Eduardo G Regis; Victor Barreto-de-Souza; Mariza G Morgado; Marcelo T Bozza; Lin Leng; Richard Bucala; Dumith C Bou-Habib
Journal:  Virology       Date:  2010-01-20       Impact factor: 3.616

8.  Hypoxia and glucocorticoid signaling converge to regulate macrophage migration inhibitory factor gene expression.

Authors:  Laura M Elsby; Rachelle Donn; Zaynab Alourfi; Laura M Green; Elaine Beaulieu; David W Ray
Journal:  Arthritis Rheum       Date:  2009-08

9.  Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.

Authors:  Kendra D Simpson; Dennis J Templeton; Janet V Cross
Journal:  J Immunol       Date:  2012-11-02       Impact factor: 5.422

10.  Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection.

Authors:  Christian Østergaard; Thomas Benfield
Journal:  Crit Care       Date:  2009       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.